Skip to main content
Aarti Drugs Limited logo

Aarti Drugs Limited — Investor Relations & Filings

Ticker · AARTIDRUGS ISIN · INE767A01016 LEI · 3358008CHU25M2YZMB20 BSE.NS Manufacturing
Open in API
Filings indexed 1,021 across all filing types
Latest filing 2026-05-23 Call Transcript
Country IN India
Listing BSE.NS AARTIDRUGS

About Aarti Drugs Limited

https://www.aartidrugs.com/

Aarti Drugs Limited specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals. The company maintains a diverse product portfolio across multiple therapeutic categories, including anti-diabetics, anti-protozoals, antibiotics, anti-inflammatories, and vitamins. Key products include Metformin, Ciprofloxacin, and Tinidazole. With a focus on large-scale production and research-driven processes, the organization serves a global clientele of pharmaceutical manufacturers. Its operations emphasize quality compliance and cost-effective manufacturing solutions to support the global healthcare supply chain.

Recent filings

Filing Released Lang Actions
Q4 & FY26 Earning Call Transcript
Call Transcript Classification · 95% confidence The document is a formal submission under SEBI Regulation 30 referencing the attached “Transcript of Q4 FY26 Earning Conference Call” to stock exchanges, followed by the full verbatim Q&A transcript of the earnings call with management and investors. This matches the definition of a Call Transcript (CT) rather than an earnings release or other filing type.
2026-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an attachment to a stock exchange filing under SEBI Regulation 30 providing the full text of the Q4 FY26 earnings conference call, including moderator and management remarks and a Q&A session. This exactly matches the definition of a Call Transcript (CT).
2026-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure under SEBI (Listing Obligations and Disclosure Requirements), Regulation 30, providing the schedule of analyst / institutional investor meetings. It is not reporting financial results, issuing an investor presentation, or filing a report; rather it is a standard regulatory announcement to stock exchanges. Therefore it falls under the general Regulatory Filings category (RNS).
2026-05-22 English
Intimation of Analyst Meet
Regulatory Filings Classification · 87% confidence The document is an exchange filing under SEBI Listing Regulations (Regulation 30) notifying the schedule of analyst/institutional investor meetings. It is not a financial report, earnings release, presentation, or management discussion document. It is a routine regulatory announcement to stock exchanges. This falls under General Regulatory Filings (RNS).
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a compliance letter filed under Regulation 30 of SEBI LODR to stock exchanges notifying the uploading of a conference call recording and forthcoming transcript. It does not contain any financial statements, actual report data, or the transcript itself, nor does it announce a board change, dividend, or other specific corporate action. This is a general regulatory announcement/fallback disclosure under SEBI listing rules, fitting the “Regulatory Filings” category (RNS).
2026-05-18 English
Audit Recording of Q4 and FY26 Earning Conference Call
Report Publication Announcement Classification · 87% confidence The document is a short regulatory letter under SEBI LODR Regulation 30 notifying the stock exchanges that the audio recording of the Q4 & FY2026 conference call has been uploaded to the company’s website and that the transcript will follow. It does not contain financial data, the actual transcript, or detailed report content, but merely provides a link to the published material. Under the “menu vs. meal” rule, this constitutes an announcement of a published report (audio recording), best classified as a Report Publication Announcement (RPA).
2026-05-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.